Developing safe therapies from human pluripotent stem cells.
about
Cell-based therapy for neural disorders--anticipating challengesMesenchymal stem cells: environmentally responsive therapeutics for regenerative medicineChanging Paradigms in Cranio-Facial Regeneration: Current and New Strategies for the Activation of Endogenous Stem CellsPluripotent stem cells: immune to the immune system?Concise review: making and using clinically compliant pluripotent stem cell linesLivestock models for exploiting the promise of pluripotent stem cellsHuman serum-derived protein removes the need for coating in defined human pluripotent stem cell culture.The importance of stem cell engineering in head and neck oncologyImproving cell-based therapies by nanomodificationInduced pluripotent stem cell potential in medicine, specifically focused on reproductive medicineEffect of antibiotics against Mycoplasma sp. on human embryonic stem cells undifferentiated status, pluripotency, cell viability and growthDerivation of xeno-free and GMP-grade human embryonic stem cells--platforms for future clinical applicationsStem cell bioprocess engineering towards cGMP production and clinical applicationsManufacturing and banking of mesenchymal stem cells.At the dawn of a new discovery: the potential of breast milk stem cells.Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.Process-based expansion and neural differentiation of human pluripotent stem cells for transplantation and disease modeling.Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells.Hurdles to clinical translation of human induced pluripotent stem cellsDevelopment of a functional schwann cell phenotype from autologous porcine bone marrow mononuclear cells for nerve repair.Bioimaging: An Useful Tool to Monitor Differentiation of Human Embryonic Stem Cells into Chondrocytes.Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease.Derivation of induced pluripotent stem cells from the baboon: a nonhuman primate model for preclinical testing of stem cell therapies.Stem cells and ethics: current issues.Converting human pluripotent stem cells into beta-cells: recent advances and future challengesAssessing the value of autologous and allogeneic cells for regenerative medicine.Albumin and mammalian cell culture: implications for biotechnology applicationsNanoparticles for cell labeling.Dermal substitute-assisted healing: enhancing stem cell therapy with novel biomaterial design.Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development.Insights into bone marrow-derived mesenchymal stem cells safety for cutaneous repair and regeneration.Translational research and therapeutic applications of stem cell transplantation in periodontal regenerative medicine.Bioprocessing of cryopreservation for large-scale banking of human pluripotent stem cells.Current status of pluripotent stem cells: moving the first therapies to the clinic.Using the cost-effectiveness of allogeneic islet transplantation to inform induced pluripotent stem cell-derived β-cell therapy reimbursement.Improvement of Cell Survival During Human Pluripotent Stem Cell Definitive Endoderm Differentiation.Scalable passaging of adherent human pluripotent stem cells.Functional screening assays with neurons generated from pluripotent stem cell-derived neural stem cells.Targeting SOX17 in human embryonic stem cells creates unique strategies for isolating and analyzing developing endodermIndividual cell movement, asymmetric colony expansion, rho-associated kinase, and E-cadherin impact the clonogenicity of human embryonic stem cells.
P2860
Q24615515-19BE9944-5AE5-4144-BF7E-529152778074Q24632756-12AFC567-78BB-481A-897A-8E1A6CFF3118Q26768579-4DAFB4DA-FA93-4BDA-A320-D815D3007A8FQ26823255-F45AC762-6CBB-49C6-B45B-9DB7F8DAFB7BQ26852128-E38A8A13-1DC6-40E7-8368-0352A918A0C2Q27011082-0E33FC52-5053-4380-BB6F-8BB99ECBCC7CQ27335859-76316408-D562-49FC-BEBD-D1CB17EAF409Q28069565-8C721F43-7F2A-4D54-BFBD-B5D3B7EE8EA8Q28080427-AA93804C-A145-4D23-AF53-2FE2846DCAF9Q28083057-D48E8AF7-F005-482B-A707-105C004706CEQ28534979-40AF1C52-C174-4D2E-9DD5-8658560071D0Q28728207-BD7CE7A8-C1F6-487E-98D4-515E12957A5BQ34150828-BD38266E-077A-4FA9-8A11-6CB9ECAF61D0Q34323739-C84BA246-AA26-49C2-B7F8-F3B29E071AC9Q34471916-2F056839-3B78-4212-B171-8EF615AD9F28Q34700964-00DDF81C-44B6-4D66-BC5E-D2AA52213330Q34841519-468640C3-0D35-4817-A6CC-C1E2B3D5E99FQ35112764-C10E900A-6E00-4A6C-AEEE-4AE77E9F1F95Q36040255-57E887BC-D639-4FFE-9852-B208074A2E52Q36072885-BAD27E0C-5687-4F4B-BFC3-5FF6E4C8F44CQ36814432-D4DEF579-C649-4F80-A892-18F57BDD058DQ37320881-ECA27CB7-EAAF-4A36-AA9B-E204D738EA28Q37359167-129C2347-4590-4BB6-B157-3DAAF03BDBEBQ37600705-B7B7555E-8FAC-4938-984A-33CE7D0D8870Q37621220-8F3D937F-75DD-4C96-88E0-CB61153DAB6AQ37630522-F84B8177-9FE2-4D07-9024-E584FF0E5DEFQ37725715-77AE8B6E-5842-4290-A572-B27F7FB6BA94Q37799541-AF3B3DCE-067F-48B4-9C54-0B6136B6D6A9Q37848691-38469578-581B-49AD-BDED-F4F198B73C5AQ37968323-9E178797-DA89-4F73-A18A-3C1A62928366Q38038901-11A64599-9F09-40D7-BF46-0E7D834B1858Q38048961-F64151E4-69D5-4800-A2FF-1D39968F3BE8Q38091624-A82F0360-2F29-4FCD-A126-414566AD5B18Q38590664-3721D599-A02D-4CDD-AAB6-BEA7D133A411Q38632041-73662B64-8B95-480E-B526-25E5E5815996Q38858174-5AAC6B7C-8FE4-478B-A082-9B8B86B5096DQ39026996-154E4BDD-AE41-470B-A978-4451907061C5Q39098071-CAE6AD46-38EB-4C39-8DD7-B38B1B11D3E9Q39583799-CE05D977-C367-494A-BCDB-91366AFF9DA1Q39698278-DC235C26-A305-4840-BBB2-6F482AC71D85
P2860
Developing safe therapies from human pluripotent stem cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Developing safe therapies from human pluripotent stem cells.
@en
Developing safe therapies from human pluripotent stem cells.
@nl
type
label
Developing safe therapies from human pluripotent stem cells.
@en
Developing safe therapies from human pluripotent stem cells.
@nl
prefLabel
Developing safe therapies from human pluripotent stem cells.
@en
Developing safe therapies from human pluripotent stem cells.
@nl
P2093
P2860
P356
P1433
P1476
Developing safe therapies from human pluripotent stem cells.
@en
P2093
Joyce Frey-Vasconcells
Mahendra S Rao
Melissa K Carpenter
P2860
P2888
P304
P356
10.1038/NBT0709-606
P577
2009-07-01T00:00:00Z